Technology for now
and the future

Scene 1

The biotech industry uses innovation and science to create life-changing new medicines. Historically, this has taken years or even decades. At Regeneron, we’ve worked to accelerate this process, by making each step more efficient.

Here’s how our process typically works –

Scene 2 

First, we identify points of potential medical intervention by studying biological processes. This is known as a ‘target’.

Scene 3 

Then, we research further and generate animal models to confirm this target works the way we think it does, and that our medicine should work as intended.

Scene 4 

Next, we use our novel technologies to invent an effective medicine. At Regeneron, we make biologics – protein medicines made in living cells.

Scene 5 

We then test our drug candidates in animal models to evaluate if they’re effective, safe and tolerable before moving into human studies.

Scene 6 

Medicines that are demonstrated to be safe in animal studies are moved into clinical trials in human volunteers, where we again rigorously evaluate safety and efficacy.

Scene 7 

Once the investigational medicine has passed all these stages, we submit our data to regulatory authorities for review and approval, manufacture the medicine on a larger scale, and deliver it to people in need.

Scene 8 

Developing a new medicine is incredibly difficult: only 8% make it from candidate selection to treating patients; and even then, the process can take over 12 years and cost over 2 billion dollars.

Scene 9 

At Regeneron, we’ve identified bottlenecks in the drug discovery and development process, and developed VelociSuite, our own toolkit of innovative technologies, to address them.

Scene 10 

Our technologies provide a greater chance of producing effective medicines that benefit human health. We deploy them at all stages of the process; which has been instrumental in developing novel therapeutic antibody medicines for diseases, including COVID-19 and Ebola.

Scene 11 

Regeneron sits at the intersection of technology and biology, and our scientists have changed the way medicines are made. We have successfully produced nine FDA-approved medicines with dozens more in the pipeline – all furthering our mission of helping people in need by turning science to medicine.